[Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
Muñoz-López
F
F
Servicio de Inmunología y Alergia Pediátrica, Hospital Clínico, Facultad de Medicina, Barcelona.
Martín Mateos
A
A
Moreira
A
A
Martínez Marín
F
F
D000281:Administration, Intranasal; D000293:Adolescent; D000818:Animals; D039741:Antigens, Dermatophagoides; D001249:Asthma / Q000209:etiology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic; D005260:Female; D005500:Follow-Up Studies; D006023:Glycoproteins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D008297:Male; D008925:Mites / Q000276:immunology; D012189:Retrospective Studies; D012221:Rhinitis, Allergic, Perennial / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome
D039741:Antigens, Dermatophagoides; D006023:Glycoproteins; D007073:Immunoglobulin E
Inmunoterapia tópica nasal con extracto de Dermatophagoides pteronyssinus.